KALA - Kala Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

KALA is currently covered by 4 analysts with an average price target of $281.38. This is a potential upside of $274.98 (4296.56%) from yesterday's end of day stock price of $6.4.

Kala Pharmaceuticals's activity chart (see below) currently has 10 price targets and 41 ratings on display. The stock rating distribution of KALA is 93.75% BUY and 6.25% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 5.73% with an average time for these price targets to be met of 26.63 days.

Highest price target for KALA is $22, Lowest price target is $15, average price target is $281.38.

Most recent stock forecast was given by FRANCOIS BRISEBOIS from OPPENHEIMER on 02-Apr-2024. First documented stock forecast 25-Oct-2017.

Currently out of the existing stock ratings of KALA, 15 are a BUY (93.75%), 1 are a SELL (6.25%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

15

$8.67 (136.97%)

15

22 days ago

0/3 (0%)

$7.01 (87.73%)

Buy

21

$14.67 (231.75%)

22

22 days ago

1/8 (12.5%)

$13.01 (162.83%)

65

Buy

22

$15.67 (247.55%)

47

5 months 10 days ago

0/2 (0%)

$16.8 (323.08%)

Buy

1 years 8 months 9 days ago

0/2 (0%)

$390 (108.33%)

Sell

75

$68.67 (1084.83%)

2 years 25 days ago

0/2 (0%)

$2 (2.74%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KALA (Kala Pharmaceuticals) average time for price targets to be met?

On average it took 26.63 days on average for the stock forecasts to be realized with a an average price target met ratio 5.73

Which analyst has the current highest performing score on KALA (Kala Pharmaceuticals) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the current lower performing score on KALA (Kala Pharmaceuticals) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on KALA (Kala Pharmaceuticals)?

Francois Brisebois works at OPPENHEIMER and has 7 price targets and 4 ratings on KALA

Which analyst is the currently most bullish on KALA (Kala Pharmaceuticals)?

Tazeen Ahmad with highest potential upside - $791.1

Which analyst is the currently most reserved on KALA (Kala Pharmaceuticals)?

Chris Schott with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?